ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2021
Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management.Journal of clinical medicine · 2024Review
- Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now!Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program.Heart failure reviews · 2022Review
- Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Article
- Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden usingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland.Cardiology and therapy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
background
methodsThe study cohort comprised 37 subjects with systemic AL amyloidosis enrolled in the prospective study: Molecular Imaging of Primary Amyloid Cardiomyopathy (clinical trials.gov NCT: 02641145). Using 10 mCi of
resultsAll reproducibility (interobserver, r = 0.98) and repeatability (intraobserver, R=0.99 for each observer) measures of
conclusionsThe present study showed excellent interobserver reproducibility and intraobserver repeatability of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.